https://scitechdaily.com/safety-of-stem-cell-therapy-for-chronic-knee-pain-confirmed-in-new-study/
Whilst I personally believe cell proliferation and regeneration from Chondrocytes superior to Mesenchymal stem-cells (though a mix having obvious benefits) a study in Japan showing that
"The results showed that five years after transplantation, osteoarthritis-related tears to the knee meniscus had healed and, just as importantly, none of the patients experienced any serious side effects from the treatment. The meniscus is a crescent-shaped cartilage in the knee joint that plays a role in shock absorption. Age-related damage to the meniscus often leads to the progression of osteoarthritis of the knee."
This is an autologous stem-cell therapy trial from five years with obvious direct comparison to OCC's ACI treatment. Stem-cells work when properly administered, we all know that, but another autologous trial having a clear efficacy result another indication of likely success in OCC's forthcoming ATI trial.
- Forums
- ASX - By Stock
- OCC
- Reminder - J&J ATI Rotator Cuff clinical trial update coming soon
Reminder - J&J ATI Rotator Cuff clinical trial update coming soon, page-118
-
- There are more pages in this discussion • 101 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OCC (ASX) to my watchlist
|
|||||
Last
40.0¢ |
Change
0.010(2.56%) |
Mkt cap ! $83.83M |
Open | High | Low | Value | Volume |
39.0¢ | 40.0¢ | 39.0¢ | $199.1K | 504.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3807 | 39.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
40.0¢ | 3666 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2599 | 0.385 |
3 | 27634 | 0.380 |
2 | 42700 | 0.375 |
4 | 23903 | 0.370 |
5 | 42071 | 0.365 |
Price($) | Vol. | No. |
---|---|---|
0.400 | 3666 | 2 |
0.405 | 74300 | 2 |
0.410 | 45237 | 4 |
0.420 | 135239 | 3 |
0.425 | 39350 | 3 |
Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
Featured News
OCC (ASX) Chart |